MPG.eBooks - Search Results - (canadian OR canada)

1

Future Horizons : Canadian Digital Humanities

by Barrett, Paul
Published 2023

University of Ottawa Press / Les Presses de l’Université d’Ottawa

Subjects: “...Canada...”

Read Now

2

CADTH Canadian Drug Expert Committee recommendation: Vedolizumab (Entyvio -- Takeda Canada Inc.)...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

3

CADTH Canadian Drug Expert Committee recommendation: Vedolizumab (Entyvio -- Takeda Canada Inc.)...

Published 2021

Canadian Agency for Drugs and Technologies in Health

“...Vedolizumab (Entyvio -- Takeda Canada Inc.)...”

Read Now

4

CADTH Canadian Drug Expert Committee recommendation: Vedolizumab (Entyvio -- Takeda Canada Inc.)...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Vedolizumab (Entyvio -- Takeda Canada Inc.)...”

Read Now

5

Shipping in Inuit Nunangat : Governance Challenges and Approaches in Canadian Arctic Waters

by Bartenstein, Kristin
Published 2023

Brill

Subjects: “...Canada / bicssc...”

Read Now

6

CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: ankylosing spondylitis

Published 2020

CADTH

“...Ixekizumab (Taltz -- Eli Lilly Canada Inc.)...”

Read Now

7

CADTH Canadian Drug Expert Committee recommendation: Dupilumab (Dupixent -- Sanofi-Aventis Canada Inc.) : indication: atopic dermatitis

Published 2020

CADTH

“...Dupilumab (Dupixent -- Sanofi-Aventis Canada Inc.)...”

Read Now

8

CADTH Canadian Drug Expert Committee recommendation: Dupilumab (Dupixent -- Sanofi-Aventis Canada Inc.) : indication: atopic dermatitis

Published 2020

CADTH

Subjects: “...Canada...”

Read Now

9

CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: ankylosing spondylitis

Published 2020

CADTH

Subjects: “...Canada...”

Read Now

10

CADTH Canadian Drug Expert Committee recommendation: Ofatumumab (Kesimpta -- Novartis...

Published 2021

Canadian Agency for Drugs and Technologies in Health

“...Ofatumumab (Kesimpta -- Novartis Hharmaceuticals Canada Inc.)...”

Read Now

11

CADTH Canadian Drug Expert Committee recommendation: Eculizumab (Soliris -- Alexion Pharma Canada...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Eculizumab (Soliris -- Alexion Pharma Canada Corp.)...”

Read Now

12

CADTH Canadian Drug Expert Committee recommendation: Eculizumab (Soliris - Alexion Pharma Canada...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Eculizumab (Soliris - Alexion Pharma Canada Corp.)...”

Read Now

13

CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

14

CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.)...”

Read Now

15

CADTH Canadian drug expert committee recommendation: Burosumab (Crysvita -- Kyowa Kirin Limited) : indication : treatment of x-linked hypophosphatemia

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

16

CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

17

CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

18

CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

19

CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

20

CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis

Published 2018

CADTH

Subjects: “...Canada...”

Narrow Search